Replimune Group announced that the U.S. Food and Drug Administration has accepted the resubmission of its Biologics License Application for RP1 in combination with nivolumab, targeting advanced ...

TIOBE Index for October 2025: Top 10 Most Popular Programming Languages Your email has been sent The October TIOBE Programming Community Index brought a few quiet but meaningful shifts. Python remains ...

There’s a touching scene in Jose Alayón’s “Dance of the Living,” which competes at San Sebastián’s New Directors, where one Canary Island wrestler has just won a bout, charging his opponent and ...

Over the last few days, Elon Musk has been making several statements claiming that autonomous driving systems that use lidar and radar sensors are more dangerous than Tesla’s camera-only computer ...

Creating a crochet blanket may seem intimidating at first, but with the right approach, it can be easier than you think! This tutorial introduces a simple yet beautiful method using the Half Double ...

This Microsoft PowerPoint tutorial for beginners will help you to learn how to start and create it. This post will give you the step by step details and tips on how to make your presentation ...

Replimune Group's RP1 oncolytic virus therapy faced an FDA rejection, raising concerns about the platform's viability in refractory melanoma. The company's pipeline is centered on RP1, making the ...

Replimune (NASDAQ:REPL) announced on Tuesday that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter regarding its marketing application for its lead asset, RP1, declining ...

Earnings call Replimune reported a net loss of $74.1M in Q4 FY25 and ended the year with $483.8M in cash, extending its runway into Q4 FY26. The company is preparing for the commercial launch of RP1 ...

Lenny Burnham grew up in Missoula, Montana. From an early age, he was obsessed with TV and loved creating websites and participating in fan forums for Buffy the Vampire Slayer. He attended New York ...